搜索临床试验以:EGFR tyrosine kinase inhibitor (EGFR TKI)
总计69350个结果
-
Chinese Academy of SciencesGuangdong Academy of Medical Sciences; West China Hospital; Shanghai Pulmonary Hospital, Shanghai...未知
-
China Medical University, China招聘中转移性结直肠腺癌 | 移动安全系统 | pMMR中国
-
Guangdong Association of Clinical Trials未知
-
The Fourth Affiliated Hospital of Zhejiang University...完全的
-
Shanghai Cancer Hospital, China未知肺癌IV期,EGFR突变,TKI,PD-L1,SBRT中国
-
Novartis Pharmaceuticals完全的
-
Hellenic Oncology Research GroupUniversity Hospital of Crete终止
-
Hellenic Oncology Research Group未知
-
Tian XieLinkDoc Technology (Beijing) Co. Ltd.主动,不招人
-
European LeukemiaNetLudwig-Maximilians - University of Munich; Heidelberg University主动,不招人
-
Tianjin Medical University Cancer Institute and...未知
-
Zhejiang Cancer Hospital未知
-
Shenzhen Second People's Hospital招聘中白血病 | 骨髓的 | 慢性的 | BCR-ABL (Breakpoint Cluster Region-abelson Murine Leukemia) | 积极的中国
-
European Society for Blood and Marrow TransplantationNovartis完全的
-
City of Hope Medical CenterNational Cancer Institute (NCI)完全的
-
Ascentage Pharma Group Inc.Suzhou Yasheng Pharmaceutical Co., Ltd.招聘中
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityJiangsu HengRui Medicine Co., Ltd.招聘中
-
Daping Hospital and the Research Institute of Surgery...尚未招聘EGFR T790M | 非小细胞肺癌 IV 期 | 非小细胞肺癌 IIIB 期
-
National OncoVentureHanmi Pharmaceutical Company Limited完全的
-
Ocular Therapeutix, Inc.Duke University; Fortrea招聘中
-
Fifth Affiliated Hospital, Sun Yat-Sen University尚未招聘化疗 | 手术 | 非小细胞肺癌 | EGFR激活突变 | 表皮生长因子受体抑制剂
-
University Hospital, Strasbourg, France未知
-
H. Lee Moffitt Cancer Center and Research Institute终止
-
First People's Hospital of Hangzhou未知
-
Kartos Therapeutics, Inc.招聘中
-
Hanmi Pharmaceutical Company Limited完全的
-
Oslo University HospitalAstraZeneca主动,不招人肺癌 | 靶向治疗瑞典, 芬兰, 丹麦, 立陶宛, 挪威